127 related articles for article (PubMed ID: 38687973)
1. The influence of breast screening on breast cancer incidence in England: observational study based on cancer registries and bulletins of the NHS Breast Screening Programme.
Autier P; Ould Ammar R; Bota M
Eur J Public Health; 2024 Apr; ():. PubMed ID: 38687973
[TBL] [Abstract][Full Text] [Related]
2. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
[TBL] [Abstract][Full Text] [Related]
3. A case-control study to evaluate the impact of the breast screening programme on breast cancer incidence in England.
Blyuss O; Dibden A; Massat NJ; Parmar D; Cuzick J; Duffy SW; Sasieni P
Cancer Med; 2023 Jan; 12(2):1878-1887. PubMed ID: 35851849
[TBL] [Abstract][Full Text] [Related]
4. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
Hendrick RE
Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
[TBL] [Abstract][Full Text] [Related]
5. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
6. Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study.
Mannu GS; Wang Z; Broggio J; Charman J; Cheung S; Kearins O; Dodwell D; Darby SC
BMJ; 2020 May; 369():m1570. PubMed ID: 32461218
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
[No Abstract] [Full Text] [Related]
8. Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme.
Michalopoulos D; Duffy SW
J Med Screen; 2016 Dec; 23(4):192-202. PubMed ID: 26940963
[TBL] [Abstract][Full Text] [Related]
9. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
[TBL] [Abstract][Full Text] [Related]
10. Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
Menon U; Gentry-Maharaj A; Burnell M; Ryan A; Kalsi JK; Singh N; Dawnay A; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Parmar M; Jacobs IJ
Health Technol Assess; 2023 May; ():1-81. PubMed ID: 37183782
[TBL] [Abstract][Full Text] [Related]
11. Atypia detected during breast screening and subsequent development of cancer: observational analysis of the Sloane atypia prospective cohort in England.
Freeman K; Jenkinson D; Clements K; Wallis MG; Pinder SE; Provenzano E; Stobart H; Stallard N; Kearins O; Sharma N; Shaaban A; Kirwan CC; Hilton B; Thompson AM; Taylor-Phillips S;
BMJ; 2024 Feb; 384():e077039. PubMed ID: 38302129
[TBL] [Abstract][Full Text] [Related]
12. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
13. The benefits and harms of breast cancer screening: an independent review.
Independent UK Panel on Breast Cancer Screening
Lancet; 2012 Nov; 380(9855):1778-86. PubMed ID: 23117178
[TBL] [Abstract][Full Text] [Related]
14. Influence of number of views and mammographic film density on the detection of invasive cancers: results from the NHS Breast Screening Programme.
Young KC; Wallis MG; Blanks RG; Moss SM
Br J Radiol; 1997 May; 70(833):482-8. PubMed ID: 9227229
[TBL] [Abstract][Full Text] [Related]
15. Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in Sweden.
Hellquist BN; Duffy SW; Nyström L; Jonsson H
J Med Screen; 2012 Mar; 19(1):14-9. PubMed ID: 22355181
[TBL] [Abstract][Full Text] [Related]
16. Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: population based cohort study.
Mannu GS; Wang Z; Dodwell D; Broggio J; Charman J; Darby SC
BMJ; 2024 Jan; 384():e075498. PubMed ID: 38267073
[TBL] [Abstract][Full Text] [Related]
17. Effect of second timed appointments for non-attenders of breast cancer screening in England: a randomised controlled trial.
Allgood PC; Maroni R; Hudson S; Offman J; Turnbull AE; Peacock L; Steel J; Kirby G; Ingram CE; Somers J; Fuller C; Threlfall AG; Gabe R; Maxwell AJ; Patnick J; Duffy SW
Lancet Oncol; 2017 Jul; 18(7):972-980. PubMed ID: 28522311
[TBL] [Abstract][Full Text] [Related]
18. The Scottish breast screening programme's experience of monitoring interval cancers.
Everington D; Gilbert FJ; Tyack C; Warner J
J Med Screen; 1999; 6(1):21-7. PubMed ID: 10321366
[TBL] [Abstract][Full Text] [Related]
19. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
Kalager M; Adami HO; Bretthauer M; Tamimi RM
Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
